Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan | Zendy

ChienYu Cheng | Zendy; Yulin Lee | Zendy; ChengPin Chen | Zendy; Yi-Chun Lin | Zendy; Chun-Eng Liu | Zendy; C Liao | Zendy; ShuHsing Cheng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

Author(s) -

ChienYu Cheng,

Yulin Lee,

ChengPin Chen,

Yi-Chun Lin,

Chun-Eng Liu,

C Liao,

ShuHsing Cheng

Publication year - 2020

Publication title -

journal of microbiology immunology and infection

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.223

H-Index - 57

eISSN - 1995-9133

pISSN - 1684-1182

DOI - 10.1016/j.jmii.2020.03.032

Subject(s) - lopinavir , lopinavir/ritonavir , ritonavir , medicine , covid-19 , pneumonia , virology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , disease , outbreak , infectious disease (medical specialty)

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research